Pharmacology of cannabinoids in the treatment of epilepsy

@article{Gaston2017PharmacologyOC,
  title={Pharmacology of cannabinoids in the treatment of epilepsy},
  author={Tyler E Gaston and D. Friedman},
  journal={Epilepsy & Behavior},
  year={2017},
  volume={70},
  pages={313-318}
}
The use of cannabis products in the treatment of epilepsy has long been of interest to researchers and clinicians alike; however, until recently very little published data were available to support its use. This article summarizes the available scientific data of pharmacology from human and animal studies on the major cannabinoids which have been of interest in the treatment of epilepsy, including ∆9-tetrahydrocannabinol (∆9-THC), cannabidiol (CBD), ∆9-tetrahydrocannabivarin (∆9-THCV… Expand
81 Citations
Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy
  • 37
Cannabis for the Treatment of Epilepsy: an Update
  • 44
Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?
  • E. Perucca
  • Medicine
  • Journal of epilepsy research
  • 2017
  • 104
  • PDF
Cannabinoid therapy in epilepsy
  • 22
The pharmacokinetics and the pharmacodynamics of cannabinoids.
  • 48
Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders.
  • 1
Investigational cannabinoids in seizure disorders, what have we learned thus far?
  • 6
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 52 REFERENCES
Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects.
  • 195
Human Cannabinoid Pharmacokinetics
  • M. Huestis
  • Chemistry, Medicine
  • Chemistry & biodiversity
  • 2007
  • 394
  • PDF
Cannabinoids and Epilepsy
  • 144
  • PDF
Pharmacokinetics and Pharmacodynamics of Cannabinoids
  • 849
  • PDF
Crystal Structure of the Human Cannabinoid Receptor CB1
  • 291
  • PDF
...
1
2
3
4
5
...